1. Home
  2. TROO vs SPRO Comparison

TROO vs SPRO Comparison

Compare TROO & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROO
  • SPRO
  • Stock Information
  • Founded
  • TROO 2005
  • SPRO 2013
  • Country
  • TROO Hong Kong
  • SPRO United States
  • Employees
  • TROO N/A
  • SPRO 32
  • Industry
  • TROO Radio And Television Broadcasting And Communications Equipment
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TROO Technology
  • SPRO Health Care
  • Exchange
  • TROO Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • TROO 103.8M
  • SPRO 121.0M
  • IPO Year
  • TROO N/A
  • SPRO 2017
  • Fundamental
  • Price
  • TROO $1.04
  • SPRO $2.01
  • Analyst Decision
  • TROO
  • SPRO Buy
  • Analyst Count
  • TROO 0
  • SPRO 4
  • Target Price
  • TROO N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • TROO 214.3K
  • SPRO 539.9K
  • Earning Date
  • TROO 09-03-2025
  • SPRO 08-12-2025
  • Dividend Yield
  • TROO N/A
  • SPRO N/A
  • EPS Growth
  • TROO N/A
  • SPRO N/A
  • EPS
  • TROO N/A
  • SPRO N/A
  • Revenue
  • TROO $10,073,000.00
  • SPRO $48,576,000.00
  • Revenue This Year
  • TROO N/A
  • SPRO N/A
  • Revenue Next Year
  • TROO N/A
  • SPRO N/A
  • P/E Ratio
  • TROO N/A
  • SPRO N/A
  • Revenue Growth
  • TROO 182.24
  • SPRO N/A
  • 52 Week Low
  • TROO $0.49
  • SPRO $0.51
  • 52 Week High
  • TROO $4.64
  • SPRO $3.22
  • Technical
  • Relative Strength Index (RSI)
  • TROO 58.49
  • SPRO 44.92
  • Support Level
  • TROO $0.92
  • SPRO $1.83
  • Resistance Level
  • TROO $1.09
  • SPRO $2.20
  • Average True Range (ATR)
  • TROO 0.10
  • SPRO 0.10
  • MACD
  • TROO -0.00
  • SPRO 0.04
  • Stochastic Oscillator
  • TROO 62.82
  • SPRO 51.62

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: